Pathogénie de la maladie de Kawasaki : quoi de neuf ?

Rowley, 1991, Kawasaki syndrome, Curr Probl Pediatr, 21, 387, 10.1016/0045-9380(91)90008-9 Cimaz, 2005, La maladie de Kawasaki : une maladie infectieuse ?, Rev Med Interne, 26, 15 Rowley, 2007, New developments in the search for the etiologic agent of Kawasaki disease, Curr Opin Pediatr, 19, 71, 10.1097/MOP.0b013e328012720f Esper, 2005, Association between a novel human coronavirus and Kawasaki disease, J Infect Dis, 191, 499, 10.1086/428291 Dominguez, 2006, Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome, J Infect Dis, 194, 1697, 10.1086/509509 Chang, 2006, Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan, J Infect Dis, 193, 283, 10.1086/498875 Shimizu, 2005, Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease, J Infect Dis, 192, 1767, 10.1086/497170 Belay, 2005, Kawasaki disease and human coronavirus, J Infect Dis, 192, 352, 10.1086/431609 Ebihara, 2005, Lack of association between New Haven coronavirus and Kawasaki disease, J Infect Dis, 192, 351, 10.1086/430797 Rowley, 1997, IgA plasma cells in vascular tissue of patients with Kawasaki syndrome, J Immunol, 159, 5946, 10.4049/jimmunol.159.12.5946 Rowley, 2000, IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease, J Infect Dis, 182, 1183, 10.1086/315832 Rowley, 2011, Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease, J Infect Dis, 203, 1021, 10.1093/infdis/jiq136 Mutter, 2008, Kawasaki's disease, acrodynia, and mercury, Curr Med Chem, 15, 3000, 10.2174/092986708786848712 Beck, 2004, Mercury intoxication: it still exists, Pediatr Dermatol, 21, 254, 10.1111/j.0736-8046.2004.21314.x Orlowski, 1980, Urine mercury levels in Kawasaki disease, Pediatrics, 66, 633, 10.1542/peds.66.4.633 Fujita, 1989, Kawasaki disease in families, Pediatrics, 84, 666, 10.1542/peds.84.4.666 Uehara, 2003, Kawasaki disease in parents and children, Acta Paediatr, 92, 694, 10.1111/j.1651-2227.2003.tb00602.x Onouchi, 2008, ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms, Nat Genet, 40, 35, 10.1038/ng.2007.59 Chi, 2010, ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children, Hum Mol Genet, 19, 1147, 10.1093/hmg/ddp586 Kuo, 2011, CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children, J Hum Genet, 56, 161, 10.1038/jhg.2010.154 Onouchi, 2010, Common variants in CASP3 confer susceptibility to Kawasaki disease, Hum Mol Genet, 19, 2898, 10.1093/hmg/ddq176 Huang, 2008, Genetic polymorphisms in the CD40-ligand gene and Kawasaki disease, J Clin Immunol, 28, 405, 10.1007/s10875-008-9203-6 Onouchi, 2004, CD40-ligand gene and Kawasaki disease, Eur J Hum Genet, 12, 1062, 10.1038/sj.ejhg.5201266 Chun, 2010, Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki disease, Eur J Pediatr, 169, 181, 10.1007/s00431-009-1002-4 Simonini, 2009, Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease, Clin Exp Rheumatol, 27, 1026 Yeung, 2010, Kawasaki disease: update on pathogenesis, Curr Opin Rheumatol, 22, 551, 10.1097/BOR.0b013e32833cf051 Curtis, 1995, Evidence for a superantigen mediated process in Kawasaki disease, Arch Dis Child, 72, 308, 10.1136/adc.72.4.308 Matsubara, 2006, Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease, Clin Exp Immunol, 143, 427, 10.1111/j.1365-2249.2006.03015.x Choi, 1997, Clonal expansion of CD8+ T cells in Kawasaki disease, J Immunol, 159, 481, 10.4049/jimmunol.159.1.481 Kato, 1995, Kawasaki disease, Coron Artery Dis, 6, 194 Brogan, 2008, T cell activation profiles in Kawasaki syndrome, Clin Exp Immunol, 151, 267, 10.1111/j.1365-2249.2007.03567.x Lehman, 1988, Variable expression of Lactobacillus casei cell wall-induced coronary arteritis: an animal model of Kawasaki's disease in selected inbred mouse strains, Clin Immunol Immunopathol, 48, 108, 10.1016/0090-1229(88)90161-4 Duong, 2003, Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease, Int Immunol, 15, 79, 10.1093/intimm/dxg007 Lehman, 1985, Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension, Arthritis Rheum, 28, 652, 10.1002/art.1780280609 Schulte, 2009, Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease, J Immunol, 183, 5311, 10.4049/jimmunol.0901395 Hui-Yuen, 2006, TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease, J Immunol, 176, 6294, 10.4049/jimmunol.176.10.6294 Lau, 2008, Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease, Arthritis Rheum, 58, 854, 10.1002/art.23225 Furukawa, 1988, Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease, Clin Immunol Immunopathol, 48, 247, 10.1016/0090-1229(88)90088-8 Lin, 1992, Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease, J Pediatr, 121, 924, 10.1016/S0022-3476(05)80343-9 Hirao, 1997, High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease, Int Arch Allergy Immunol, 112, 152, 10.1159/000237447 Leung, 1989, Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease, Lancet, 2, 1298, 10.1016/S0140-6736(89)91910-7